Target
Substance-P receptor
Ligand
BDBM50114932
Substrate
n/a
Meas. Tech.
ChEBML_205739
IC50
6.3±n/a nM
Citation
 Elliott, JMCastro, JLChicchi, GGCooper, LCDinnell, KHollingworth, GJRidgill, MPRycroft, WKurtz, MMShaw, DESwain, CJTsao, KLYang, L 4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists I. Bioorg Med Chem Lett 12:1755-8 (2002) [PubMed]  Article 
Target
Name:
Substance-P receptor
Synonyms:
NK-1 receptor | NK-1R | NK1 Receptor | NK1R | NK1R_HUMAN | Neurokinin 1 receptor | Neurokinin-1 (NK-1) | Neuromedin-1 receptor (NK-1R) | SPR | TAC1R | TACR1 | Tachykinin receptor 1 | Tachykinin receptor 1 (NK1) | tachykinin
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
46254.43
Organism:
Homo sapiens (Human)
Description:
P25103
Residue:
407
Sequence:
MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGAHEEEPEDGPKATPSSLDLTSNCSSRSDSKTMTESFSFSSNVLS
  
Inhibitor
Name:
BDBM50114932
Synonyms:
CHEMBL301618 | N-{4-[4-(4-Fluoro-phenyl)-piperidin-1-yl]-1-phenyl-cyclohexylmethyl}-3,5-bis-trifluoromethyl-benzamide
Type:
Small organic molecule
Emp. Form.:
C33H33F7N2O
Mol. Mass.:
606.6167
SMILES:
Fc1ccc(cc1)C1CCN(CC1)C1CCC(CNC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)(CC1)c1ccccc1 |(6.21,-13.79,;6.21,-12.25,;4.88,-11.48,;4.88,-9.94,;6.21,-9.17,;7.54,-9.94,;7.54,-11.46,;6.21,-7.63,;4.88,-6.87,;4.88,-5.33,;6.21,-4.55,;7.54,-5.33,;7.54,-6.87,;6.21,-3.01,;7.56,-2.25,;7.56,-.72,;6.23,.06,;7.56,.84,;8.89,.07,;10.22,.84,;10.2,2.38,;11.55,.07,;12.88,.84,;14.21,.07,;14.22,-1.47,;12.88,-2.24,;11.55,-1.47,;12.86,-3.78,;11.53,-4.55,;14.21,-4.55,;11.39,-3.38,;15.54,.84,;15.94,-.64,;16.88,.09,;15.54,2.38,;4.88,-.7,;4.88,-2.25,;4.88,.83,;4.88,2.38,;3.55,3.15,;2.2,2.38,;2.22,.82,;3.55,.06,)|
Structure:
Search PDB for entries with ligand similarity: